---
title: "NPC plans to list for lease the real estate located at No. 27 Yanling Alley, Qinhuai District, Nanjing"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/246028554.md"
description: "NPC announced plans to publicly list for lease the real estate located at No. 27 Yanling Lane, Qinhuai District, Nanjing. The assessed rent is RMB 7.1155 million, with a leased area of 13,325.11 square meters, a lease term of 13 years, a rent-free period of 6 months, and a fixed rent for the first three years, followed by a 5% increase every three years. The total expected rental income over 13 years is RMB 97.0973 million, and the final transaction price will be determined based on the listing results"
datetime: "2025-06-25T07:35:03.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/246028554.md)
  - [en](https://longbridge.com/en/news/246028554.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/246028554.md)
generator: "portal-rs"
---

# NPC plans to list for lease the real estate located at No. 27 Yanling Alley, Qinhuai District, Nanjing

According to the Zhitong Finance APP, Nanjing Pharmaceutical (600713.SH) announced that the company intends to lease its property located at No. 27 Yanling Lane, Qinhuai District, Nanjing, through a public listing.

The assessed value of the first-year rent based on the assessment benchmark date for this property is RMB 7.1155 million, and the assessment result has been filed with the state-owned assets regulatory department. The total area for lease is 13,325.11 square meters (subject to the actual leasable area), with a lease term of 13 years (156 months, with a rent-free period of 6 months, evenly distributed over the first three years). Rent will be paid quarterly, with the rent price remaining unchanged for the first three years, starting to increase from the fourth year, with a 5% increase every three years based on the previous year's rent. The total rental income for the 13-year lease period is expected to be RMB 97.0973 million. The final transaction price and the assignee will be determined based on the results of the public listing

### Related Stocks

- [600713.CN](https://longbridge.com/en/quote/600713.CN.md)

## Related News & Research

- [Fosun Pharma subsidiary Shanghai Fosun Pharmaceutical Industrial Development wins China approval for new Luvometinib use in adult NF1 tumors](https://longbridge.com/en/news/297890174.md)
- [Hybrid Power Solutions Inc. Files Patent Application for Advanced AI-Powered Energy Management System](https://longbridge.com/en/news/297787562.md)
- [Biocytogen and Qilu Pharmaceutical sign agreement for VHH antibody molecule](https://longbridge.com/en/news/297892535.md)
- [20:00 ETWuXi AppTec Continues to Reward Shareholders, Further Increasing Interim Dividend to RMB 1.51 Billion](https://longbridge.com/en/news/297441220.md)
- [Hartalega answers shareholder questions ahead of AGM](https://longbridge.com/en/news/297881237.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**